Muscle quality and not quantity as a predictor of survival in head and neck squamous cell carcinoma

E Roberti, M Merlano, M Ravanelli, A Alberti… - Oral Oncology, 2023 - Elsevier
Background Sarcopenia is frequent in head and neck squamous cell carcinoma (HNSCC),
as a consequence of malnutrition related to risk factors or tumoral mass. Treatment is …

Impact of low skeletal muscle mass in oropharyngeal cancer patients treated with radical chemo-radiotherapy: A mono-institutional experience

CL Deantoni, A Mirabile, A Chiara, L Giannini… - Tumori …, 2024 - journals.sagepub.com
Aims: Low skeletal muscle mass index (SMI) has recently emerged as an independent
prognostic factor in oncological patients and it is linked with poor survival and higher …

[HTML][HTML] The prognostic significance of sarcopenia in patients treated with definitive radiotherapy: A systematic review

AJ Vickers, DM McSweeney, A Choudhury… - Radiotherapy and …, 2024 - Elsevier
Sarcopenia describes the degenerative loss of muscle mass and strength, and is emerging
as a pan-cancer prognostic biomarker. It is linked with increased treatment toxicity …